HOOPER ANTHONY C
SEC insider (Form 3/4/5 filer). CIK 0001277244. Director at BeOne Medicines Ltd. (ONC) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BASEL.
Companies HOOPER ANTHONY C has filed insider reports for
- BeOne Medicines Ltd. (ONC): Director
- MANNKIND CORP (MNKD): Director
HOOPER ANTHONY C
CIK: 0001277244
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)6 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 11, 2026ONC
BeOne Medicines Ltd.
AwardDirect19K shares- - May 20, 2026MNKD
MANNKIND CORP
AwardDirectRestricted Stock Unit
82.8K shares- - May 20, 2026MNKD
MANNKIND CORP
AwardDirectRestricted Stock Unit
16.6K shares- - Mar 1, 2026MNKD
MANNKIND CORP
AwardDirect35K shares at avg. $3.27$114K - May 21, 2025BGNE
BeiGene, Ltd.
AwardDirect11K shares- - May 14, 2025MNKD
MANNKIND CORP
AwardDirect25K shares at avg. $4.56$114K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  ONC BeOne Medicines Ltd. | Award | 18,980 | - | $0 | Direct |
| May 20, 2026 |  MNKD MANNKIND CORP | Award Restricted Stock Unit | 82,781 | - | - | Direct |
| May 20, 2026 | MNKD MANNKIND CORP | Award Restricted Stock Unit | 16,556 | - | - | Direct |
| Mar 1, 2026 | MNKD MANNKIND CORP | Award | 35,000 | $3.27 | $114,450 | Direct |
| May 21, 2025 |  BGNE BeiGene, Ltd. | Award | 10,985 | - | - | Direct |
| May 14, 2025 | MNKD MANNKIND CORP | Award | 25,000 | $4.56 | $114,000 | Direct |
1-6 of 6 transactions